Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News AGNC Investment Corp AGNC

Alternate Symbol(s):  AGNCN

Real Estate
AGNC Investment Corp. is an internally managed real estate investment trust (REIT). The Company provides private capital to the United States housing market, enhancing liquidity in the residential real estate mortgage markets and, in turn, facilitating home ownership in the United States. The Company invest primarily in Agency residential mortgage-backed securities (Agency RMBS) on a leveraged... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AGNC)

AGNC Investment Corp. Publishes Fourth Annual Environmental, Social & Governance Report

PR Newswire 8 days ago

AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for November 2024

PR Newswire November 7, 2024

AGNC Investment Corp. Announces Third Quarter 2024 Financial Results

PR Newswire October 21, 2024

AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for October 2024

PR Newswire October 9, 2024

AGNC Investment Corp. Announces Date for Third Quarter Earnings Release and Stockholder Call

PR Newswire October 8, 2024

AGNC Investment Corp. Declares Third Quarter Dividends on Preferred Stock

PR Newswire September 13, 2024

AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for September 2024

PR Newswire September 13, 2024

AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for August 2024

PR Newswire August 8, 2024

AGNC Investment Corp. Announces Second Quarter 2024 Financial Results

PR Newswire July 22, 2024
View More News ››

Opinion & Analysis (NDAQ:AGNC)

4 Top Performing Mortgage REITs Rise Sharply On Wells Fargo Sector Upgrade

Benzinga.com  July 8, 2015

The Jobs Number Could Signal Trouble For This Group Of ETFs

Benzinga.com  December 9, 2014

These stocks are paying 17% dividends

Tom Dyson February 26, 2010
View More Opinion ››

Bullboard Posts (NDAQ:AGNC)

Want $500 in Annual Dividend Income? Invest $4,100 in These

News; $AGNC Want $500 in Annual Dividend Income? Invest $4,100 in These 2 Ultra-High-Yield Dividend Stocks.2024-09-02 04:43:00 ET Folks...
whytestocks - September 2, 2024

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
LeaMiles - April 13, 2023

$AGN.v up 30% today

$AGN.v up 30% today   They announced  Dr. David L. Brody has  been appointed an consultant.  Brody, a board...
stockpatrol - March 3, 2023

Progress from AGN DMT clinical stroke research program

Algernon Pharmaceuticals announces that they’ve initiated their DMT clinical stroke research program with their Phase 1 study in the...
biggonads - November 17, 2022

AGN.c CEO Chris Moreau discussing Phase 2 of the Yale clinic

AGN.c CEO Chris Moreau discussing Phase 2 of the Yale clinical trial for DMT.    https://www.youtube.com/watch?app...
stockpatrol - November 2, 2022

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
LeaMiles - July 15, 2022
View more Bullboard ››

Visionstate Corp.

Visionstate Corp.

Visionstate Corp.is a growth-oriented company that invests in the research and development of the Internet of Things, big ...
View More »